Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine

Authors :: Yftach Gepner
Merav Mofaz
Shay Oved
Matan Yechezkel
Keren Constantini
Nir Goldstein
Arik Eisenkraft
Erez Shmueli
Dan Yamin
Source :: Communications Medicine, Vol 2, Iss 1, Pp 1-8 (2022)
Publication Year :: 2022
Publisher :: Nature Portfolio, 2022.
Abstract: Gepner et al. undertake a prospective observational study using a chest-patch sensor to monitor cardiovascular and hemodynamic vital signs following the BNT162b2 COVID-19 (Pfizer BioNTech) vaccine. Continuous and significant changes occurred in the vital signs, including in participants who did not report any reactions.

Full Text Access

Tools